Results 71 to 80 of about 52,021 (277)
Visceral Leishmaniasis Treatment, Italy [PDF]
First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Italy. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%.
Luigi Gradoni+2 more
openaire +3 more sources
A Longstanding Case of Black Grain Mycetoma in a Somalian Male Patient: A Case Report
ABSTRACT Mycetoma is a chronic granulomatous infection predominantly affecting young individuals, characterized by painless swelling and often misdiagnosed due to its resemblance to other conditions. This case report presents the first documented instance of eumycetoma located in the buttock of a 44‐year‐old male patient from Somalia, a region with ...
Mohamed Adam Mahamud+6 more
wiley +1 more source
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery
Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs 2–3 years after an apparently successful treatment of visceral leishmaniasis (VL).
Md. Mehedi Hasan+6 more
doaj +1 more source
Challenges in Modeling Complexity of Neglected Tropical Diseases: Assessment of Visceral Leishmaniasis Dynamics in Resource Limited Settings [PDF]
Neglected tropical diseases (NTD), particularly vector-borne diseases (VBD), account for a large proportion of the global disease burden, and their control faces several challenges including diminishing human and financial resources for those distressed from such diseases.
arxiv
Development of a LAMP assay for detection of Leishmania infantum infection in dogs using conjunctival swab samples [PDF]
Background: Leishmania infantum infections in dogs play a crucial role in the transmission of pathogens causing visceral leishmaniasis to humans in the Gansu province, northwest China. To be able to control zoonotic transmission of the parasite to humans,
A Moshfe+48 more
core +1 more source
HIV-associated visceral leishmaniasis [PDF]
Visceral leishmaniasis (VL) is a severe disease caused by protozoa of the genus Leishmania that usually affects immunocompetent hosts in endemic areas [1,2]. Since the mid-1980s, VL has been recognized as an opportunistic infection associated with some immunodeficiency states, such as neoplasms, organ transplantation, or treatment with ...
Vicente Pintado, R. López-Vélez
openaire +3 more sources
Removal of DDT from Aqueous solution using Carbon Quantum Dots. ABSTRACT Dichlorodiphenyltrichloroethane (DDT) pollution is an ongoing worldwide environmental hazard due to its persistence and detrimental impact on ecosystems. Carbon quantum dots (CQD) made from dried mushroom biomass using a sustainable and eco‐friendly synthesis process are ...
Sathish Sundararaman+7 more
wiley +1 more source
Leishmaniasis–HIV coinfection: current challenges
José Angelo Lauletta Lindoso,1,2 Mirella Alves Cunha,3 Igor Thiago Queiroz,4 Carlos Henrique Valente Moreira2 1Laboratory of Soroepidemiology (LIM HC-FMUSP), São Paulo University, São Paulo, 2Instituto de Infectologia Emilio ...
Lindoso JAL+3 more
doaj
Zoonotic visceral leishmaniasis (ZVL), caused by protozoans of the genus Leishmania, it is a worldwide of great importance disease. In the northeast region of Brazil, the state of Alagoas has an endemic status for ZVL.
M. A. N. Rocha+3 more
doaj +1 more source
Insights on adaptive and innate immunity in canine leishmaniosis [PDF]
Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a systemic disease, which can present with variable clinical signs, and clinicopathological abnormalities.
Abi Abdallah+19 more
core +3 more sources